Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Leukemia

Free Subscription Articles published in Leuk Lymphoma Retrieve available abstracts of 342 articles: HTML format

Single Articles

April 2008
1. POLAKOVA KM , Zmekova V, Rulcova J, Klamova H, et al
   BCR-ABL mutations in chronic myeloid leukemia - Not only detection.
   Leuk Lymphoma. 2008;:1-3.
   PubMed     Related articles   
   
   
   
2. NIU YP , Li LD, Wu LM
   Beta-aescin: A potent natural inhibitor of proliferation and inducer of apoptosis in human chronic myeloid leukemia K562 cells in vitro.
   Leuk Lymphoma. 2008;:1-8.
   PubMed     Related articles    Abstract available
   
   
   
3. TAJEDDINE N , Louis M, Vermylen C, Gala JL, et al
   Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.
   Leuk Lymphoma. 2008;:1-9.
   PubMed     Related articles    Abstract available
   
   
   
4. RINALDI CR , Martinelli V, Rinaldi P, Ciancia R, et al
   GATA1 is overexpressed in patients with essential thrombocythemia and polycythemia vera but not in patients with primary myelofibrosis or chronic myelogenous leukemia.
   Leuk Lymphoma. 2008;:1-4.
   PubMed     Related articles   
   
   
   
5. THOMAS X , Dombret H
   Treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
   Leuk Lymphoma. 2008;:1-9.
   PubMed     Related articles    Abstract available
   
   
   
6. SERRANO E , Carnicer MJ, Orantes V, Estivill C, et al
   Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype.
   Leuk Lymphoma. 2008;:1-6.
   PubMed     Related articles    Abstract available
   
   
   
7. VIENS D , St-Hilaire E, Beauregard P, Dufresne J, et al
   Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
   Leuk Lymphoma. 2008;:1-3.
   PubMed     Related articles   
   
   
   
8. WHITE DL
   Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?
   Leuk Lymphoma. 2008;:1-2.
   PubMed     Related articles   
   
   
   
9. MINTZ EM , Marneros A, Grossman ME
   Leukemic leonine facies: A manifestation of chronic lymphocytic leukemia.
   Leuk Lymphoma. 2008;:1-3.
   PubMed     Related articles   
   
   
   
10. SCHLABERG R , Fisher JG, Flamm MJ, Murty VV, et al
    Chronic myeloid leukemia and HIV-infection.
    Leuk Lymphoma. 2008;:1-6.
    PubMed     Related articles    Abstract available
    
    
    
11. WETZLER M , Donohue KA, Odenike OM, Feldman EJ, et al
    Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia - Cancer and leukemia group B study 10107.
    Leuk Lymphoma. 2008;:1-5.
    PubMed     Related articles    Abstract available
    
    
    
12. VERMA D , Kantarjian H, Jain N, Cortes J, et al
    Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha.
    Leuk Lymphoma. 2008;:1-4.
    PubMed     Related articles   
    
    
    
13. PROCHOREC-SOBIESZEK M , Chelstowska M, Rymkiewicz G, Majewski M, et al
    Biclonal T-cell receptor gammadelta+ large granular lymphocyte leukemia associated with rheumatoid arthritis.
    Leuk Lymphoma. 2008;49:828-31.
    PubMed     Related articles   
    
    
    
14. BROWN NM , Keck G, Ford PA
    Acute myeloid leukemia in Jehovah Witnesses.
    Leuk Lymphoma. 2008;49:817-20.
    PubMed     Related articles   
    
    
    
15. SAULNIER PJ , Dalbies F, Berthou C, Guilhot F, et al
    Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy.
    Leuk Lymphoma. 2008;49:815-6.
    PubMed     Related articles   
    
    
    
16. ADAMS DJ , Sandvold ML, Myhren F, Jacobsen TF, et al
    Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
    Leuk Lymphoma. 2008;49:786-97.
    PubMed     Related articles    Abstract available
    
    
    
17. GALLIGAN L , Catherwood MA, Matthews C, Morris TC, et al
    Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:763-8.
    PubMed     Related articles    Abstract available
    
    
    
18. KIKUCHI A , Mori T, Fujimoto J, Kumagai M, et al
    Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.
    Leuk Lymphoma. 2008;49:757-62.
    PubMed     Related articles    Abstract available
    
    
    
19. YU Z , Sun B, Kantarjian HM, Keating MJ, et al
    Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators.
    Leuk Lymphoma. 2008;49:751-6.
    PubMed     Related articles    Abstract available
    
    
    
20. TSURUSAWA M , Taga T, Horikoshi Y, Ogawa A, et al
    Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group.
    Leuk Lymphoma. 2008;49:734-9.
    PubMed     Related articles    Abstract available
    
    
    
21. KHAN NI , Cisterne A, Devidas M, Shuster J, et al
    Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics.
    Leuk Lymphoma. 2008;49:710-8.
    PubMed     Related articles    Abstract available
    
    
    
22. LEE JH , Min YH, Chung CW, Kim BK, et al
    Prognostic implications of the immunophenotype in biphenotypic acute leukemia.
    Leuk Lymphoma. 2008;49:700-9.
    PubMed     Related articles    Abstract available
    
    
    
23. HARTMANN EM , Rosenwald A
    Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?
    Leuk Lymphoma. 2008;49:648-9.
    PubMed     Related articles   
    
    
    
24. SCHMIDT S , Gastl G, Wolf D
    Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:643-7.
    PubMed     Related articles    Abstract available
    
    
    
25. CLARK RE , Davies A, Pirmohamed M, Giannoudis A, et al
    Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:639-42.
    PubMed     Related articles    Abstract available
    
    
    
26. VALENT P , Agis H, Sperr W, Sillaber C, et al
    Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:635-8.
    PubMed     Related articles    Abstract available
    
    
    
27. GUILHOT F , Roy L, Saulnier PJ, Guilhot J, et al
    Immunotherapeutic approaches in chronic myelogenous leukemia.
    Leuk Lymphoma. 2008;49:629-34.
    PubMed     Related articles    Abstract available
    
    
    
28. SAGLIO G , Ulisciani S, Bosa M, Cilloni D, et al
    New therapeutic approaches and prognostic factors in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:625-8.
    PubMed     Related articles    Abstract available
    
    
    
29. VALENT P , Deininger M
    Clinical perspectives of concepts on neoplastic stem cells and stem cell-resistance in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:604-9.
    PubMed     Related articles    Abstract available
    
    
    
30. ARLINGHAUS R , Leng X
    Requirement of lipocalin 2 for chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:600-3.
    PubMed     Related articles    Abstract available
    
    
    
31. VALENT P
    Targets and targeted drugs in chronic myeloid leukemia.
    Leuk Lymphoma. 2008;49:599.
    PubMed     Related articles   
    
    
    March 2008
32. VINY AD , Lichtin A, Pohlman B, Loughran TP, et al
    Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia.
    Leuk Lymphoma. 2008;:1-7.
    PubMed     Related articles    Abstract available
    
    
    
33. CHEUNG KC , Wong LG, Yeung YM
    Treatment of CD33 positive refractory acute lymphoblastic leukemia with Mylotarg.
    Leuk Lymphoma. 2008;49:596-7.
    PubMed     Related articles   
    
    
    
34. CAMPIOTTI L , Appio L, Casalone R, Righi R, et al
    Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality.
    Leuk Lymphoma. 2008;49:592-5.
    PubMed     Related articles   
    
    
    
35. KIM A , Cook R, Wainwright L, Biegel J, et al
    Dramatic response of acute monoblastic leukemia to a single dose of docetaxel.
    Leuk Lymphoma. 2008;49:577-80.
    PubMed     Related articles   
    
    
    
36. HROMADNIKOVA I , Sedlackova L
    Analysis of cell surface and relative gene expression of heat shock protein 70 in human leukemia cell lines.
    Leuk Lymphoma. 2008;49:570-6.
    PubMed     Related articles    Abstract available
    
    
    
37. RAJAPPA S , Varadpande L, Paul T, Jacob R, et al
    Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country.
    Leuk Lymphoma. 2008;49:554-8.
    PubMed     Related articles    Abstract available
    
    
    
38. FRANKEL A , Liu JS, Rizzieri D, Hogge D, et al
    Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia.
    Leuk Lymphoma. 2008;49:543-53.
    PubMed     Related articles    Abstract available
    
    
    
39. GORDON MK , Sher D, Karrison T, Kebriaei P, et al
    Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
    Leuk Lymphoma. 2008;49:531-7.
    PubMed     Related articles    Abstract available
    
    
    
40. MI Y , Xue Y, Yu W, Liu S, et al
    Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.
    Leuk Lymphoma. 2008;49:524-30.
    PubMed     Related articles    Abstract available
    
    
    
41. LANE S , Saal R, Mollee P, Jones M, et al
    A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse.
    Leuk Lymphoma. 2008;49:517-23.
    PubMed     Related articles    Abstract available
    
    
    
42. NAHI H , Lehmann S, Bengtzen S, Jansson M, et al
    Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
    Leuk Lymphoma. 2008;49:508-16.
    PubMed     Related articles    Abstract available
    
    
    
43. HAMALAINEN S , Kuittinen T, Matinlauri I, Nousiainen T, et al
    Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.
    Leuk Lymphoma. 2008;49:495-501.
    PubMed     Related articles    Abstract available
    
    
    
44. GU LJ , Li J, Xue HL, Tang JY, et al
    Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China.
    Leuk Lymphoma. 2008;49:488-94.
    PubMed     Related articles    Abstract available
    
    
    
45. THELANDER EF , Ichimura K, Corcoran M, Barbany G, et al
    Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia.
    Leuk Lymphoma. 2008;49:477-87.
    PubMed     Related articles    Abstract available
    
    
    
46. BURKHARDT B , Moericke A, Klapper W, Greene F, et al
    Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
    Leuk Lymphoma. 2008;49:451-61.
    PubMed     Related articles    Abstract available
    
    
    
47. O'MAHONY D , Debnath I, Janik J, Aisner D, et al
    Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience.
    Leuk Lymphoma. 2008;49:439-46.
    PubMed     Related articles    Abstract available
    
    
    
48. FOTOOHI AK , Albertioni F
    Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells.
    Leuk Lymphoma. 2008;49:410-26.
    PubMed     Related articles    Abstract available
    
    
    
49. WAHLIN A
    Accumulating evidence for a role of p53 in multiple drug resistant acute myeloid leukemia.
    Leuk Lymphoma. 2008;49:383-4.
    PubMed     Related articles   
    
    
    
50. ARTZ A , Pitrak D
    Separating correlation from prediction: C-reactive protein and infectious complications after chemotherapy for acute myeloid leukemia.
    Leuk Lymphoma. 2008;49:381-2.
    PubMed     Related articles   
    
    
    
51. RIBEIRO R , Pui CH
    Treatment of acute lymphoblastic leukemia in low- and middle-income countries: challenges and opportunities.
    Leuk Lymphoma. 2008;49:373-6.
    PubMed     Related articles   
    
    
    
52. KOBAYASHI K , Yokote T, Akioka T, Hara S, et al
    Granulocyte colony-stimulating factor and interleukin-6 production by myelodysplastic syndrome blasts.
    Leuk Lymphoma. 2008;49:589-91.
    PubMed     Related articles   
    
    
    February 2008
53. KYATHARI S , Chao K, Liu D, Seiter K, et al
    Severe imatinib-associated muscle edema in patients with chronic myelogenous leukemia and marked leukocytosis.
    Leuk Lymphoma. 2008;:1-3.
    PubMed     Related articles   
    
    
    
54. ZENZ T , Mertens D, Dohner H, Stilgenbauer S, et al
    Molecular diagnostics in chronic lymphocytic leukemia - Pathogenetic and clinical implications.
    Leuk Lymphoma. 2008;:1-10.
    PubMed     Related articles    Abstract available
    
    
    
55. PRATZ KW , Levis M
    Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens.
    Leuk Lymphoma. 2008;:1-12.
    PubMed     Related articles    Abstract available
    
    
    
56. OSTRONOFF F , Ostronoff M, Fernandes HS, Buessio R, et al
    Evidence for a graft-versus-leukemia effect in the central nervous system.
    Leuk Lymphoma. 2008;49:365-9.
    PubMed     Related articles   
    
    
    
57. REID A , Naresh K, Wagner S, Macdonald D, et al
    Interphase FISH using a BCL3 probe to diagnose the t(14;19)(q32;q13)-positive small B-cell leukemia.
    Leuk Lymphoma. 2008;49:356-8.
    PubMed     Related articles   
    
    
    
58. RAYCHAUDHURI J , Cualing H, Haider K, Kharfan-Dabaja MA, et al
    Granulocytic sarcoma and chronic lymphocytic leukemia of the gastrointestinal tract after allogeneic hematopoietic cell transplantation mimicking graft-versus-host disease.
    Leuk Lymphoma. 2008;49:350-2.
    PubMed     Related articles   
    
    
    
59. KOBAYASHI S , Sato K, Torikai H, Ogura K, et al
    Transformation of myelodysplastic syndrome into myeloid/natural killer cell precursor acute leukemia involving mainly lymph nodes.
    Leuk Lymphoma. 2008;49:342-5.
    PubMed     Related articles   
    
    
    
60. LOURENCO MT , Walsh A, Boon H, Al-Khabouri M, et al
    Superstition but not distrust in the medical system predicts the use of complementary and alternative medicine in a group of patients with acute leukemia.
    Leuk Lymphoma. 2008;49:339-41.
    PubMed     Related articles   
    
    
    
61. LU L , Zhang L, Xiao Z, Lu S, et al
    Neuropilin-1 in acute myeloid leukemia: Expression and role in proliferation and migration of leukemia cells.
    Leuk Lymphoma. 2008;49:331-8.
    PubMed     Related articles    Abstract available
    
    
    
62. INOUE H , Matsushita K, Arima N, Hamada H, et al
    High prevalence of human T-lymphotropic virus type I carriers among patients with myelodysplastic syndrome refractory anemia with excess of blasts (RAEB), RAEB in transformation and acute promyelocytic leukemia.
    Leuk Lymphoma. 2008;49:315-21.
    PubMed     Related articles    Abstract available
    
    
    
63. OMRAN H , Shabani M, Vossough P, Sharifian R, et al
    Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission.
    Leuk Lymphoma. 2008;49:281-90.
    PubMed     Related articles    Abstract available
    
    
    
64. CRAIG F , Soma L, Melan M, Kant J, et al
    MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:273-80.
    PubMed     Related articles    Abstract available
    
    
    
65. BRODERICK P , Sellick G, Fielding S, Catovsky D, et al
    Lack of a relationship between the common 18q24 variant rs12953717 and risk of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:271-2.
    PubMed     Related articles    Abstract available
    
    
    
66. KCHOUR G , Tarhini M, Sharifi N, Farid R, et al
    Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma.
    Leuk Lymphoma. 2008;49:265-70.
    PubMed     Related articles    Abstract available
    
    
    
67. GUILLEM V , Tormo M
    Influence of DNA damage and repair upon the risk of treatment related leukemia.
    Leuk Lymphoma. 2008;49:204-17.
    PubMed     Related articles    Abstract available
    
    
    
68. HAMMOND SP , Baden LR
    Antibiotic prophylaxis for patients with acute leukemia.
    Leuk Lymphoma. 2008;49:183-93.
    PubMed     Related articles    Abstract available
    
    
    
69. ZENT CS
    The role of alemtuzumab in the treatment of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:175-6.
    PubMed     Related articles   
    
    
    
70. BURKE LP , Kukoly CA
    Statins induce lethal effects in acute myeloblastic lymphoma cells within 72 hours.
    Leuk Lymphoma. 2008;49:322-30.
    PubMed     Related articles    Abstract available
    
    
    
71. KRAJ M , Sokolowska U, Kopec-Szlezak J, Poglod R, et al
    Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma.
    Leuk Lymphoma. 2008;49:298-305.
    PubMed     Related articles    Abstract available
    
    
    
72. ZHANG L , Arrington S, Keung YK
    Guillain-Barre syndrome after transplantation.
    Leuk Lymphoma. 2008;49:291-7.
    PubMed     Related articles    Abstract available
    
    
    
73. HUI D , Lam W, Toze C, Delorme M, et al
    Alemtuzumab in clinical practice: a British Columbia experience.
    Leuk Lymphoma. 2008;49:218-26.
    PubMed     Related articles    Abstract available
    
    
    January 2008
74. BABUSIKOVA O , Zeleznikova T, Kirschnerova G, Kankuri E, et al
    Hematogones in acute leukemia during and after therapy.
    Leuk Lymphoma. 2008;:1-10.
    PubMed     Related articles    Abstract available
    
    
    
75. 
    Reviewers for Leukemia & Lymphoma during 2007.
    Leuk Lymphoma. 2008;49:171-4.
    PubMed     Related articles   
    
    
    
76. THERY JC , Jardin F, Massy N, Massy J, et al
    Optical neuropathy possibly related to arsenic during acute promyelocytic leukemia treatment.
    Leuk Lymphoma. 2008;49:168-70.
    PubMed     Related articles   
    
    
    
77. DERENZINI E , Paolini S, Martinelli G, Campidelli C, et al
    Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: A diagnostic and therapeutic challenge.
    Leuk Lymphoma. 2008;49:159-62.
    PubMed     Related articles   
    
    
    
78. PODDA L , Fozza C, Nieddu R, Sanna S, et al
    Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: Clinical features and diagnostic issues.
    Leuk Lymphoma. 2008;49:154-5.
    PubMed     Related articles   
    
    
    
79. SELLICK G , Fielding S, Qureshi M, Catovsky D, et al
    Germline mutations in RAD51, RAD51AP1, RAD51B, RAD51C,RAD51D, RAD52 and RAD54L do not contribute to familial chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:130-3.
    PubMed     Related articles    Abstract available
    
    
    
80. MOLICA S , Vitelli G, Cutrona G, Todoerti K, et al
    Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:62-7.
    PubMed     Related articles    Abstract available
    
    
    
81. THURMES P , Call T, Slager S, Zent C, et al
    Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia.
    Leuk Lymphoma. 2008;49:49-56.
    PubMed     Related articles    Abstract available
    
    
    
82. KENNEY B , Zieske A, Rinder H, Smith B, et al
    DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia.
    Leuk Lymphoma. 2008;49:42-8.
    PubMed     Related articles    Abstract available
    
    
    
83. LI S
    Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.
    Leuk Lymphoma. 2008;49:19-26.
    PubMed     Related articles    Abstract available
    
    
    
84. POLLIACK A , van Besien K, Seymour JF
    2007: The year in review for Leukemia and Lymphoma.
    Leuk Lymphoma. 2008;49:1-3.
    PubMed     Related articles   
    
    
    
85. LEWIS R , Hogan H, Howell A, Safdar A, et al
    Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection.
    Leuk Lymphoma. 2008;49:163-5.
    PubMed     Related articles   
    
    
    
86. PETRICH A , Kahl B, Bailey H, Kim K, et al
    Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome.
    Leuk Lymphoma. 2008;49:57-61.
    PubMed     Related articles    Abstract available
    
    
    
87. SIPKINS DA
    Chemotherapy and the bone marrow stroma.
    Leuk Lymphoma. 2008;49:17-8.
    PubMed     Related articles   
    
    
    
88. JONSSON V , Samuelsen SO, Tjonnfjord G, Johannesen T, et al
    Looking for CLL genes.
    Leuk Lymphoma. 2008;49:10-1.
    PubMed     Related articles   
    
    
    December 2007
89. GARCIA-MUNOZ R , Galar A, Moreno C, Rodriguez-Otero P, et al
    Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).
    Leuk Lymphoma. 2007;48:2461-4.
    PubMed     Related articles   
    
    
    
90. BROWN A , Niggli F, Hengartner H, Caflisch U, et al
    Characterization of high-hyperdiploidy in childhood acute lymphoblastic leukemia with gain of a single chromosome 21.
    Leuk Lymphoma. 2007;48:2457-60.
    PubMed     Related articles   
    
    
    
91. YILMAZ M , Demirhan O, Kucukosmanoglu E, Pehlivan M, et al
    Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
    Leuk Lymphoma. 2007;48:2454-6.
    PubMed     Related articles   
    
    
    
92. FORCONI F , Toraldo F, Sozzi E, Amato T, et al
    Complete molecular remission induced by concomitant Cladribine - Rituximab treatment in a case of multi-resistant Hairy Cell Leukemia.
    Leuk Lymphoma. 2007;48:2441-3.
    PubMed     Related articles   
    
    
    
93. SCHOLL S , Melle C, Bleul A, Spies-Weisshart B, et al
    Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations.
    Leuk Lymphoma. 2007;48:2418-23.
    PubMed     Related articles    Abstract available
    
    
    
94. BOWEN DA , Call TG, Jenkins GD, Zent CS, et al
    Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features.
    Leuk Lymphoma. 2007;48:2412-7.
    PubMed     Related articles    Abstract available
    
    
    
95. CAPRA M , Vilella L, Pereira WV, Coser VM, et al
    Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil.
    Leuk Lymphoma. 2007;48:2381-6.
    PubMed     Related articles    Abstract available
    
    
    
96. SHIMONI A , Hardan I, Shem-Tov N, Rand A, et al
    Fludarabine and treosulfan: A novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.
    Leuk Lymphoma. 2007;48:2352-9.
    PubMed     Related articles    Abstract available
    
    
    
97. KUJAWSKI L , Talpaz M
    Strategies for overcoming imatinib resistance in chronic myeloid leukemia.
    Leuk Lymphoma. 2007;48:2310-22.
    PubMed     Related articles    Abstract available
    
    
    
98. GOLDMAN J
    Chronic myeloid leukemia - Therapy in the 20(th) and 21(st) centuries.
    Leuk Lymphoma. 2007;48:2287-8.
    PubMed     Related articles   
    
    
    
99. CATOVSKY D
    The changing face of chronic lymphocytic leukemia.
    Leuk Lymphoma. 2007;48:2283-4.
    PubMed     Related articles   
    
    
    
100. 
     Leukemia - Past and Present A scientific meeting in memory of Prof David Galton.
     Leuk Lymphoma. 2007;48:2279.
     PubMed     Related articles   
     
     
     
101. JONSSON V , Tjonnfjord G, Samuelsen SO, Johannesen T, et al
     Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease.
     Leuk Lymphoma. 2007;48:2387-96.
     PubMed     Related articles    Abstract available
     
     
     
102. TORRES HA , Chemaly RF
     Viral infection or reactivation in patients during treatment with dasatinib: a call for screening?
     Leuk Lymphoma. 2007;48:2308-9.
     PubMed     Related articles   
     
     
     
103. GADI VK
     Chronic lymphocytic lymphoma: Another example of parental favoritism?
     Leuk Lymphoma. 2007;48:2306-7.
     PubMed     Related articles   
     
     
     
104. RUND D
     FLT3 internal tandem duplication in low risk MDS: clinical and basic science relevance.
     Leuk Lymphoma. 2007;48:2302-3.
     PubMed     Related articles   
     
     
     
105. DYER M
     David Galton--the thesis years.
     Leuk Lymphoma. 2007;48:2290-1.
     PubMed     Related articles   
     
     
     
106. BURNETT A
     MRC trials in acute myeloblastic luekemia: where have we got to?
     Leuk Lymphoma. 2007;48:2289-90.
     PubMed     Related articles   
     
     
     
107. BAIN B
     FAB and beyond.
     Leuk Lymphoma. 2007;48:2282-3.
     PubMed     Related articles   
     
     
     
108. GREAVES M
     Godwits and blast crises: in memory of David Galton.
     Leuk Lymphoma. 2007;48:2280-2.
     PubMed     Related articles   
     
     
     November 2007
109. 
     The abstracts to follow form an addendum to those already published in Leukemia & Lymphoma Volume 48 Supplement 1 (2007).
     Leuk Lymphoma. 2007;48:2264-74.
     PubMed     Related articles   
     
     
     
110. OZPUYAN F , Meyer P, Ni H, Al-Masri H, et al
     Bortezomib induces apoptosis in T-cell prolymphocytic leukemia (T-PLL).
     Leuk Lymphoma. 2007;48:2247-50.
     PubMed     Related articles   
     
     
     
111. SHISEKI M , Kitagawa Y, Wang YH, Yoshinaga K, et al
     Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.
     Leuk Lymphoma. 2007;48:2141-4.
     PubMed     Related articles    Abstract available
     
     
     
112. FALINI B
     Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities?
     Leuk Lymphoma. 2007;48:2093-5.
     PubMed     Related articles   
     
     
     
113. 
     Additional abstracts from the XII International Workshop on Chronic Lymphocytic Leukemia. September 14-16, 2007. London, United Kingdom.
     Leuk Lymphoma. 2007;48:2267-74.
     PubMed     Related articles   
     
     
     
114. SPERR W , Valent P
     Biology and clinical features of myeloid neoplasms with inv(3)(q21q26) or t(3;3)(q21q26).
     Leuk Lymphoma. 2007;48:2096-7.
     PubMed     Related articles   
     
     
     
115. WEISSER M , Haferlach C, Haferlach T, Schnittger S, et al
     Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.
     Leuk Lymphoma. 2007;48:2145-51.
     PubMed     Related articles    Abstract available
     
     
     
116. MENG Y , Li Y, Li J, Li H, et al
     (-)Gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemic cells.
     Leuk Lymphoma. 2007;48:2204-12.
     PubMed     Related articles    Abstract available
     
     
     
117. RAJAPPA S , Varadpande L, Paul TR, Digumarti R, et al
     Imatinib mesylate induced immune thrombocytopenia.
     Leuk Lymphoma. 2007;48:2261-3.
     PubMed     Related articles   
     
     
     
118. AU WY , Tam S, Fong BM, Ho KL, et al
     Prolonged oral arsenic trioxide therapy and nephrolithiasis [corrected]
     Leuk Lymphoma. 2007;48:2233-4.
     PubMed     Related articles   
     
     
     October 2007
119. MOSHAVER B , Van Der Pol MA, Westra AH, Ossenkoppele GJ, et al
     Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival.
     Leuk Lymphoma. 2007;:1-15.
     PubMed     Related articles    Abstract available
     
     
     
120. MIAO KR , Pan QQ, Xue M, Fan S, et al
     Human leukocyte antigens in 295 Chinese patients with chronic myeloid leukemia.
     Leuk Lymphoma. 2007;:1-5.
     PubMed     Related articles    Abstract available
     
     
     
121. LANDSTROM AP , Knudson RA, Dewald GW, Ketterling RP, et al
     Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: Clinical correlates and effect on imatinib mesylate treatment outcome.
     Leuk Lymphoma. 2007;:1-4.
     PubMed     Related articles    Abstract available
     
     
     
122. KUBICKA M , Soszynska K, Mucha B, Rafinska B, et al
     Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement.
     Leuk Lymphoma. 2007;48:2083-6.
     PubMed     Related articles   
     
     
     
123. BARR P , Fu P, Lazarus H, Kane D, et al
     Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia.
     Leuk Lymphoma. 2007;48:1940-9.
     PubMed     Related articles    Abstract available
     
     
     
124. TAM CS , O'brien S, Lerner S, Khouri I, et al
     The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.
     Leuk Lymphoma. 2007;48:1931-9.
     PubMed     Related articles    Abstract available
     
     
     
125. REDDICONTO G , Chiusolo P, Fiorini A, Farina G, et al
     Dasatinib restores full donor chimerism in a patient with imatinib-resistant Ph+ ALL relapsing after unrelated cord blood transplantation.
     Leuk Lymphoma. 2007;48:2054-7.
     PubMed     Related articles   
     
     
     
126. MEYER B , Krisponeit D, Junghanss C, Escobar HM, et al
     Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.
     Leuk Lymphoma. 2007;48:2008-13.
     PubMed     Related articles    Abstract available
     
     
     
127. VALES A , Kondo R, Aichberger KJ, Mayerhofer M, et al
     Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.
     Leuk Lymphoma. 2007;48:1997-2007.
     PubMed     Related articles    Abstract available
     
     
     
128. GODLEY LA
     HMGA2 levels in CML: reflective of miRNA gene regulation in a hematopoietic tumor?
     Leuk Lymphoma. 2007;48:1898-9.
     PubMed     Related articles   
     
     
     
129. MULLIGAN SP
     Chronic lymphocytic leukaemia resistant to both fludarabine and alemtuzumab--double jeopardy.
     Leuk Lymphoma. 2007;48:1885-7.
     PubMed     Related articles   
     
     
     
130. KANTARJIAN HM , Jeha S, Gandhi V, Wess M, et al
     Clofarabine: past, present, and future.
     Leuk Lymphoma. 2007;48:1922-30.
     PubMed     Related articles    Abstract available
     
     
     September 2007
131. AKKER JV , Coppo P, Portnoi MF, Barbu V, et al
     Simultaneous regression of Philadelphia chromosome and multiple nonrecurrent clonal chromosomal abnormalities with imatinib mesylate in a patient autografted 22 years before for chronic myelogenous leukemia.
     Leuk Lymphoma. 2007;48:1858-65.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
132. MCCLUNE B , Buadi FK, Aslam N, Przepiorka D, et al
     Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.
     Leuk Lymphoma. 2007;48:1849-51.
     PubMed     Related articles       Free Full Text
     
     
     
133. CHEN L , Li J, Zheng W, Zhang Y, et al
     The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:1785-92.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
134. JAMALI FR , Otrock ZK, Soweid AM, Al-Awar GN, et al
     An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma (corrected and republished article originally printed in Leukemia & Lymphoma, June 2007; 48(6): 1237 - 1241).
     Leuk Lymphoma. 2007;48:1780-4.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
135. ROSENWALD A
     CLLU1 expression: The latest risk predictor in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:1665-6.
     PubMed     Related articles       Free Full Text
     
     
     
136. FLANAGAN SA , Gandhi V, Meckling KA
     Guanosine acts intracellularly to initiate apoptosis in NB4 cells: A role for nucleoside transport.
     Leuk Lymphoma. 2007;48:1816-27.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
137. UYTTEBROECK A , Vanhentenrijk V, Hagemeijer A, Boeckx N, et al
     Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?
     Leuk Lymphoma. 2007;48:1745-54.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
138. PUI CH
     Toward optimal use of intrathecal liposomal cytarabine.
     Leuk Lymphoma. 2007;48:1672-3.
     PubMed     Related articles       Free Full Text
     
     
     
139. 
     Abstracts from the XII International Workshop on CLL (chronic lymphocytic leukemia), 14-16 September 2007, London, United Kingdom.
     Leuk Lymphoma. 2007;48 Suppl 1:S3-186.
     PubMed     Related articles   
     
     
     August 2007
140. SAHNI C , Desai S
     Primary testicular precursor B-lymphoblastic lymphoma: A rare entity.
     Leuk Lymphoma. 2007;:1-3.
     PubMed     Related articles   
     
     
     
141. DISPERATI P , Minden MD, Gupta V, Schimmer AD, et al
     Acute promyelocytic leukemia in patients aged 70 years and over - A single center experience of unselected patients.
     Leuk Lymphoma. 2007;48:1654-8.
     PubMed     Related articles   
     
     
     
142. HU Q , Popa I, Fu K, Chen M, et al
     Clonal CD8+ lymphocytic proliferation associated with Epstein-Barr virus infection mimicking T-cell leukemia.
     Leuk Lymphoma. 2007;48:1651-3.
     PubMed     Related articles   
     
     
     
143. WILLIMOTT S , Baou M, Huf S, Wagner SD, et al
     Separate cell culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:1647-50.
     PubMed     Related articles   
     
     
     
144. STEENSMA DP , Friday BB
     Monocytic skin nodules in chronic myelomonocytic leukemia: Clinical response to decitabine therapy.
     Leuk Lymphoma. 2007;48:1628-9.
     PubMed     Related articles   
     
     
     
145. SRIVASTAVA MD , Thomas A, Srivastava BI, Check JH, et al
     Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.
     Leuk Lymphoma. 2007;48:1610-7.
     PubMed     Related articles    Abstract available
     
     
     
146. WANG X , Ji C, Ma D, Zhao J, et al
     Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
     Leuk Lymphoma. 2007;48:1600-9.
     PubMed     Related articles    Abstract available
     
     
     
147. HAN HS , Rybicki LA, Thiel K, Kalaycio ME, et al
     White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia.
     Leuk Lymphoma. 2007;48:1561-8.
     PubMed     Related articles    Abstract available
     
     
     
148. GUILLAUME N , Gouilleux-Gruart V, Claisse JF, Troussard X, et al
     Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:1556-60.
     PubMed     Related articles    Abstract available
     
     
     
149. HERISHANU Y , Wiestner A
     Prognostic factors for risk-adapted therapy in chronic lymphocytic leukemia - The search continues.
     Leuk Lymphoma. 2007;48:1468-9.
     PubMed     Related articles   
     
     
     
150. SOHN SK , Moon JH, Cho YY, Chae YS, et al
     Efficacy of dose escalation of imatinib mesylate in patients with cytogenetic or hematologic resistance.
     Leuk Lymphoma. 2007;48:1659-61.
     PubMed     Related articles   
     
     
     
151. RODDIE C , Cwynarski K, Craig C, Diss T, et al
     Hodgkin transformation of newly diagnosed small lymphocytic lymphoma in the gastrointestinal tract.
     Leuk Lymphoma. 2007;48:1644-6.
     PubMed     Related articles   
     
     
     
152. DU JW , Gu JY, Liu J, Cen XN, et al
     TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
     Leuk Lymphoma. 2007;48:1618-27.
     PubMed     Related articles    Abstract available
     
     
     
153. QUINEY C , Billard C, Faussat AM, Salanoubat C, et al
     Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells.
     Leuk Lymphoma. 2007;48:1587-99.
     PubMed     Related articles    Abstract available
     
     
     
154. VENER C , Carrabba M, Fracchiolla NS, Costa A, et al
     Invasive fungal sinusitis: an effective combined treatment in five haematological patients.
     Leuk Lymphoma. 2007;48:1577-86.
     PubMed     Related articles    Abstract available
     
     
     
155. MEIROW D , Baum M, Yaron R, Levron J, et al
     Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience.
     Leuk Lymphoma. 2007;48:1569-76.
     PubMed     Related articles    Abstract available
     
     
     
156. RUND D
     Hyperforin modulation of drug resistance: saint or sinner?
     Leuk Lymphoma. 2007;48:1470-1.
     PubMed     Related articles   
     
     
     July 2007
157. ALI R , Beksac M, Ozkalemkas F, Ozkocaman V, et al
     Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.
     Leuk Lymphoma. 2007;48:1426-8.
     PubMed     Related articles   
     
     
     
158. BENSON DM JR , Smith MK
     Effectiveness of lenalidomide (Revlimid) for the treatment of plasma cell leukemia.
     Leuk Lymphoma. 2007;48:1423-5.
     PubMed     Related articles   
     
     
     
159. BAE SY , Yoon SY, Huh JH, Sung HJ, et al
     Hypereosinophilia in biphenotypic (B-cell/T-cell) acute lymphoblastic leukemia.
     Leuk Lymphoma. 2007;48:1417-9.
     PubMed     Related articles   
     
     
     
160. AU WY , Wong KY, Wan TS, So JC, et al
     Very late relapse of B cell lymphoma masquerading as blastic transformation of chronic myeloid leukemia.
     Leuk Lymphoma. 2007;48:1414-6.
     PubMed     Related articles   
     
     
     
161. SELLICK GS , Lubbe SJ, Matutes E, Catovsky D, et al
     Microsatellite instability indicative of defects in the major mismatch repair genes is rare in patients with B-cell chronic lymphocytic leukemia: Evaluation with disease stage and family history.
     Leuk Lymphoma. 2007;48:1320-2.
     PubMed     Related articles    Abstract available
     
     
     
162. BLUM KA , Johnson JL, Niedzwiecki D, Canellos GP, et al
     Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206.
     Leuk Lymphoma. 2007;48:1313-1319.
     PubMed     Related articles    Abstract available
     
     
     
163. ROMAN-GOMEZ J , Jimenez-Velasco A, Barrios M, Prosper F, et al
     Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
     Leuk Lymphoma. 2007;48:1269-82.
     PubMed     Related articles    Abstract available
     
     
     
164. CHOW KU , Nowak D, Trepohl B, Hochmuth S, et al
     The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines.
     Leuk Lymphoma. 2007;48:1379-88.
     PubMed     Related articles    Abstract available
     
     
     
165. LI X , Wu L, Ying S, Chang C, et al
     Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes.
     Leuk Lymphoma. 2007;48:1353-71.
     PubMed     Related articles    Abstract available
     
     
     
166. MAHMUD N , Saunthararajah Y
     Differentiation impairment and the evolution of MDS.
     Leuk Lymphoma. 2007;48:1267-8.
     PubMed     Related articles   
     
     
     June 2007
167. ROUSHAN N , Shahi F, Mirzazadeh A, Dormohammadi T, et al
     Acute leukemia presenting with ascites and confusion.
     Leuk Lymphoma. 2007;48:1234-6.
     PubMed     Related articles   
     
     
     
168. PELLOSO LA , Da Silva ID, De Souza NC, Yamamoto M, et al
     CYP1A1 polymorphisms modify overall survival in acute myeloid leukemia patients.
     Leuk Lymphoma. 2007;48:1211-1215.
     PubMed     Related articles   
     
     
     
169. MALHOTRA P MD ASSISTANT PROFES, Varma S, Varma N, Kumari S, et al
     Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting.
     Leuk Lymphoma. 2007;48:1173-1178.
     PubMed     Related articles    Abstract available
     
     
     
170. BERAN M , Wen S, Shen Y, Onida F, et al
     Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M.D. Anderson Prognostic Scoring System.
     Leuk Lymphoma. 2007;48:1150-60.
     PubMed     Related articles    Abstract available
     
     
     
171. TOBIN G PHD
     The immunoglobulin genes: Structure and specificity in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:1081-1086.
     PubMed     Related articles    Abstract available
     
     
     
172. D'ARENA G MD , Cascavilla N
     Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
     Leuk Lymphoma. 2007;48:1072-1080.
     PubMed     Related articles    Abstract available
     
     
     
173. CIL T , Kaplan MA, Altintas A, Pasa S, et al
     Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: A case report.
     Leuk Lymphoma. 2007;48:1247-9.
     PubMed     Related articles   
     
     
     
174. ROSS DM , Jackson SR, Browett PJ
     Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia.
     Leuk Lymphoma. 2007;48:1231-3.
     PubMed     Related articles   
     
     
     
175. POULAIN S , Benard C, Daudignon A, Le Baron F, et al
     Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia?
     Leuk Lymphoma. 2007;48:1219-21.
     PubMed     Related articles   
     
     
     
176. GUO XL , Pan L, Zhang XJ, Suo XH, et al
     Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
     Leuk Lymphoma. 2007;48:1200-7.
     PubMed     Related articles    Abstract available
     
     
     
177. BARBARROJA N , Aristides-Torres L, Hernandez V, Martin C, et al
     Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia.
     Leuk Lymphoma. 2007;48:1187-99.
     PubMed     Related articles    Abstract available
     
     
     
178. YILDIRIM M , Paydas S, Tanriverdi K, Seydaoglu G, et al
     Gravin gene expression in acute leukaemias: clinical importance and review of the literature.
     Leuk Lymphoma. 2007;48:1167-72.
     PubMed     Related articles    Abstract available
     
     
     
179. STRUPP C , Knipp S, Hartmann J, Gattermann N, et al
     A pilot study of bendamustine in elderly patients with high-risk MDS and AML.
     Leuk Lymphoma. 2007;48:1161-6.
     PubMed     Related articles    Abstract available
     
     
     
180. HAUSWIRTH AW , Skrabs C, Schutzinger C, Gaiger A, et al
     Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.
     Leuk Lymphoma. 2007;48:1139-49.
     PubMed     Related articles    Abstract available
     
     
     
181. FUNG SS , Hillier KL, Leger CS, Sandhu I, et al
     Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
     Leuk Lymphoma. 2007;48:1087-91.
     PubMed     Related articles    Abstract available
     
     
     
182. JAMIL K , Reddy H
     Can polymorphisms in genes relate to overall survival in leukemias?
     Leuk Lymphoma. 2007;48:1070-1.
     PubMed     Related articles   
     
     
     
183. GILES FJ
     Bendamustine and cloretazine: alkylators with sharply contrasting activity in AML.
     Leuk Lymphoma. 2007;48:1064-6.
     PubMed     Related articles   
     
     
     
184. HAMBLIN TJ
     ZAP-70 levels do change in CLL but not very often.
     Leuk Lymphoma. 2007;48:1059-60.
     PubMed     Related articles   
     
     
     
185. RAWSTRON AC
     Monoclonal B-cell lymphocytosis: good news for patients and CLL investigators.
     Leuk Lymphoma. 2007;48:1057-8.
     PubMed     Related articles   
     
     
     May 2007
186. ABDELHALIM A , Barcos M, Block AW, Sait SN, et al
     Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.
     Leuk Lymphoma. 2007;48:1053-6.
     PubMed     Related articles   
     
     
     
187. CHUANG SS , Chang ST, Huang WT, Li CY, et al
     Variant hairy cell leukemia without distinct nucleoli.
     Leuk Lymphoma. 2007;48:1050-2.
     PubMed     Related articles   
     
     
     
188. OZKAN A , Taskapilioglu O, Bican A, Ozkocaman V, et al
     Hairy cell leukemia presenting with Guillain-Barre syndrome.
     Leuk Lymphoma. 2007;48:1048-9.
     PubMed     Related articles   
     
     
     
189. SZMIGIELSKA-KAPLON A , Jesionek-Kupnicka D, Gora-Tybor J, Blonski JZ, et al
     Influence of cladribine alone and in combinaton with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:1042-4.
     PubMed     Related articles   
     
     
     
190. PATEL S , Liu D, Caron P, Seiter K, et al
     Acute myelogenous leukemia following irinotecan-based chemotherapy for adenocarcinoma of the small intestine.
     Leuk Lymphoma. 2007;48:1032-3.
     PubMed     Related articles   
     
     
     
191. OSTRO D , Cheung K, Kamel-Reid S, Lipton JH, et al
     Chromosomal abnormalities in chronic myeloid leukemia: Evidence of a hierarchy in imatinib treated cells.
     Leuk Lymphoma. 2007;48:1029-31.
     PubMed     Related articles   
     
     
     
192. MAHIPAL A , Bilgrami S
     Acquired hemophilia in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:1026-8.
     PubMed     Related articles   
     
     
     
193. YING SX , Seal S, Abbassi N, Hockenbery DM, et al
     Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines.
     Leuk Lymphoma. 2007;48:1003-14.
     PubMed     Related articles    Abstract available
     
     
     
194. KIM ST , Jung CW, Lee J, Kwon JM, et al
     Postremission therapy for acute myeloid leukemia in the first remission.
     Leuk Lymphoma. 2007;48:937-43.
     PubMed     Related articles    Abstract available
     
     
     
195. ZALEWSKA-SZEWCZYK B , Andrzejewski W, Mlynarski W, Jedrychowska-Danska K, et al
     The anti-asparagines antibodies correlate with l-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia.
     Leuk Lymphoma. 2007;48:931-6.
     PubMed     Related articles    Abstract available
     
     
     
196. NIKITIN EA , Malakho SG, Biderman BV, Baranova AV, et al
     Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:912-22.
     PubMed     Related articles    Abstract available
     
     
     
197. PETERSON BA , Johnson J, Shipp MA, Barcos M, et al
     High dose CHOP: A phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
     Leuk Lymphoma. 2007;48:870-80.
     PubMed     Related articles    Abstract available
     
     
     
198. MOLICA S
     Immunomodulatory drugs in chronic lymphocytic leukemia: A new treatment paradigm.
     Leuk Lymphoma. 2007;48:866-9.
     PubMed     Related articles    Abstract available
     
     
     
199. ROBAK E , Robak T
     Skin lesions in chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:855-65.
     PubMed     Related articles    Abstract available
     
     
     
200. MANN G , Steiner M, Attarbaschi A
     Clinical significance of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
     Leuk Lymphoma. 2007;48:849-50.
     PubMed     Related articles   
     
     
     
201. SEPPA L , Hengartner H, Leibundgut K, Kuhne T, et al
     Loss of i(8)(q10) at relapse in two cases of childhood acute myeloid leukaemia.
     Leuk Lymphoma. 2007;48:1045-7.
     PubMed     Related articles   
     
     
     
202. TORRES F , Ivanova-Dragoeva A, Pereira M, Veiga J, et al
     An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation.
     Leuk Lymphoma. 2007;48:1034-7.
     PubMed     Related articles   
     
     
     
203. FUJIWARA S , Yamashita Y, Choi YL, Watanabe H, et al
     Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening.
     Leuk Lymphoma. 2007;48:978-86.
     PubMed     Related articles    Abstract available
     
     
     
204. JIE H , Donghua H, Xingkui X, Liang G, et al
     Homoharringtonine-induced apoptosis of MDS cell line MUTZ-1 cells is mediated by the endoplasmic reticulum stress pathway.
     Leuk Lymphoma. 2007;48:964-77.
     PubMed     Related articles    Abstract available
     
     
     
205. SROCK S , Schriever F, Neubauer A, Herold M, et al
     Long-term treatment with rituximab is feasible in selected patients with B-CLL: response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy.
     Leuk Lymphoma. 2007;48:905-11.
     PubMed     Related articles    Abstract available
     
     
     April 2007
206. NARIMATSU H , Murata M, Sugimoto K, Terakura S, et al
     Successful umbilical cord blood transplantation using a reduced-intensity preparative regimen without total body irradiation and tacrolimus plus methotrexate for prophylaxis of graft-versus-host disease in a patient with adult T-cell leukemia/lymphoma
     Leuk Lymphoma. 2007;48:841-3.
     PubMed     Related articles   
     
     
     
207. BRECCIA M , Gentilini F, Guarini A, de Propris MS, et al
     Haemolytic uremic syndrome during induction therapy in an acute promyelocytic leukemia patient with aberrant phenotype: A possible manifestation of retinoic acid syndrome.
     Leuk Lymphoma. 2007;48:833-4.
     PubMed     Related articles   
     
     
     
208. SAMARA MA , Brennan JM, Van Besien K, Larson RA, et al
     Cardiac tamponade in a patient with chronic lymphocytic leukemia.
     Leuk Lymphoma. 2007;48:829-32.
     PubMed     Related articles   
     
     
     
209. QUINTAS-CARDAMA A , Kantarjian H, Cortes J
     The daunting task of modeling response to imatinib therapy in patients with chronic myelogenous leukemia.
     Leuk Lymphoma. 2007;48:802-4.
     PubMed     Related articles   
     
     
     
210. MERKEROVA M , Bruchova H, Kracmarova A, Klamova H, et al
     Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation.
     Leuk Lymphoma. 2007;48:793-801.
     PubMed     Related articles    Abstract available
     
     
     
211. PETRA BG , Janez J, Vita D
     Gene - gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children.
     Leuk Lymphoma. 2007;48:786-92.
     PubMed     Related articles    Abstract available
     
     
     
212. MAK DH , Schober WD, Chen W, Heller J, et al
     Tetra-O-methyl nordihydroguaiaretic acid inhibits growth and induces death of leukemia cells independent of Cdc2 and survivin.
     Leuk Lymphoma. 2007;48:774-85.
     PubMed     Related articles    Abstract available
     
     
     
213. LEE EM , Bachmann PS, Lock RB
     Xenograft models for the preclinical evaluation of new therapies in acute leukemia.
     Leuk Lymphoma. 2007;48:659-68.
     PubMed     Related articles    Abstract available
     
     
     
214. NIEVA J , Saven A
     Understanding hairy cell leukemia genetics.
     Leuk Lymphoma. 2007;48:653-4.
     PubMed     Related articles   
     
     
     
215. YAO R , Schneider E
     Detection of B- and T-cell-specific gene rearrangements in 13 cell lines and 50 clinical specimens using the BIOMED-2 and the original InVivoScribe primers.
     Leuk Lymphoma. 2007;48:837-40.
     PubMed     Related articles   
     
     
     
216. RUMI E , Passamonti F, Zibellini S, Martinetti M, et al
     HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia.
     Leuk Lymphoma. 2007;48:805-7.
     PubMed     Related articles   
     
     
     March 2007
217. ROMANI C , Murru R, Pettinau M, Origa R, et al
     Sudden cardiac failure in a beta-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia.
     Leuk Lymphoma. 2007;48:628-9.
     PubMed     Related articles   
     
     
     
218. D'ARENA G , de Filippi R, Pinto A
     DAT-negative hemolytic anemia in a chronic lymphocytic leukemia patient treated with alemtuzumab.
     Leuk Lymphoma. 2007;48:625-7.
     PubMed     Related articles   
     
     
     
219. MOLETI ML , Testi AM, Giona F, Malandruccolo L, et al
     CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: A 15-year monocentric experience.
     Leuk Lymphoma. 2007;48:551-9.
     PubMed     Related articles    Abstract available
     
     
     
220. LIPTON JH , Khoroshko N, Golenkov A, Abdulkadyrov K, et al
     Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys(R)) versus interferon alpha-2a (Roferon(R)-A) in patients with treatment-naive, chronic-phase chronic myelogenous leukemia.
     Leuk Lymphoma. 2007;48:497-505.
     PubMed     Related articles    Abstract available
     
     
     
221. ZAYED A , Couban S, Hayne O, Sparavalo N, et al
     Acute promyelocytic leukemia: A novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance.
     Leuk Lymphoma. 2007;48:489-96.
     PubMed     Related articles    Abstract available
     
     
     
222. FRAGOSO R , Elias AP, Dias S
     Autocrine VEGF loops, signaling pathwa